Translational Cancer Research Is Indexed in Scopus

News

Translational Cancer Research is indexed in Scopus

Nancy Q. Zhong

Editorial Office, AME Publishing Company, Guangzhou 510220, China Correspondence to: Nancy Q. Zhong. Editorial Office, AME Publishing Company, Guangzhou 510220, China. Email: [email protected].

Submitted Aug 10, 2015. Accepted for publication Aug 10, 2015. doi: 10.3978/j.issn.2218-676X.2015.08.13 View this article at: http://dx.doi.org/10.3978/j.issn.2218-676X.2015.08.13

With pleasure, we are here to announce that Translational • “Nanotechnology in Radiation Research” (Rao V. L. Cancer Research (TCR) has been accepted for inclusion Papineni, University of Kansas Medical Center; Pataje in Scopus. Within months, article titles, abstracts, and G. Prasanna & Mansoor M. Ahmed, National Cancer references of TCR articles will be searchable in Scopus. It Institute, National Institutes of Health); is hopeful that more researchers and clinicians could access • “Stem Cell in Cancer” (Daohong Zhou, University of TCR articles via the Scopus database with the inclusion. Arkansas for Medical Sciences; Chuan-Yuan Li, Duke Scopus is the largest abstract and citation database of University Medical Center); peer-reviewed literature, featuring smart tools to track, • “Liver Cancer” (Catherine T. Frenette, Scripps Center analyze and visualize research (1). It is appreciated that the for Organ and Cell Transplantation); Scopus evaluation team comment on the journal as “a well • “IORT I & II” (Frederik Wenz & Elena Sperk & presented journal with high quality content”. Frederik Wenz, University of Heidelberg; Pedro Lara, Translational Cancer Research (Transl Cancer Res, TCR; University of Las Palmas); Print ISSN: 2218-676X; Online ISSN 2219-6803; www. • “Statistical and Bioinformatics Applications in thetcr.org), is an open access, peer-reviewed journal Biomedical Omics Research” (Dung-Tsa Chen & Yian launched in June 2012. It publishes the results of novel Ann Chen, Moffitt Cancer Center); research investigations which bridge the laboratory and • “SBRT/SRS in Radiation Research” (Sandra clinical settings including risk assessment, cellular and Vermuelen, Swedish Medical Center; Kevin T. Murphy, molecular characterization, prevention, detection, diagnosis University of California; Huan Giap, Scripps Proton and treatment of human cancers with the overall goal of Therapy Center); improving the clinical care of oncology patients, aiming to • “High Intensity Focused Ultrasound” (Giusi Irma Forte promote a rapid exchange of scientific information between & Giorgio Russo, 1Istituto di Bioimmagini e Fisiologia clinicians and scientists worldwide. Molecolare); The operation of TCR is driven by the leadership and • “Epithelial Ovarian Cancer Treatment: Integrating passion of Editor-in-Chief, Prof. Eric Chuang; co-Editor- Molecular Targeting” (Franco Muggia & Eleonora in-Chief, Dr. Huan Giap; and Associate Editor-in-Chief, Teplinsky, New York University Langone Medical Dr. Binghe Xu. They devote their time and bring their Center); decades of experience in scientific research and publications • “Application of Genomic Technologies in Cancer in managing this journal. TCR has now been published 19 Research” (Jian-Bing Fan, PhD, Southern Medical issues including 13 focused issues respectively on topics as University). followed: More focused issues on topics respectively of recent • “Particle Beam Therapy I & II” (Huan Giap, Scripps advances in radiotherapy and targeted therapies for lung Proton Therapy Center); cancer, “Lysophospholipids on Immunity and Cancer” • “DNA Damage and Repair” (Benjamin P. C. Chen & “Pancreatic Cancer”, “Combinatorial Cancer Therapy- David J. Chen, U. Texas Southwestern Medical Center Bench to Personalized Medicine”, “Radiation Induced at Dallas); Cancer”, and “Circulating Tumor Cells” etc., are now

© Translational Cancer Research. All rights reserved. www.thetcr.org Transl Cancer Res 2015;4(4):449-450 450 Zhong. Translational Cancer Research is indexed in Scopus proceeding with efforts of the editors. Conflicts of Interest: The author has completed the ICMJE In addition to the coming indexing of titles, abstracts and uniform disclosure form (available at http://dx.doi. references in Scopus, TCR owns the OJS system that deal org/10.3978/j.issn.2218-676X.2015.08.13). Nancy Q. with manuscripts from submission, reviewing to decision Zhong reports that she is a full-time employee of the making to ensure short term of turnaround vary from one publisher of the journal, AME Publishing Company. week to 2 months. No article process fee or publication fee is required to publish in TCR. We highly encourage you to Ethical Statement: The author is accountable for all submit your manuscripts to TCR. aspects of the work in ensuring that questions related TCR Editorial Team: to the accuracy or integrity of any part of the work are Eric Y. Chuang, Sc.D, Editor-in-Chief; appropriately investigated and resolved. Huan Giap, MD, PhD, MD, co-Editor-in- Chief; Binghe Xu, Prof., MD, PhD, Associate Editor-in- Open Access Statement: This is an Open Access article Chief; distributed in accordance with the Creative Commons Nancy Q. Zhong, Corresponding Editor; Attribution-NonCommercial-NoDerivs 4.0 International Molly J. Wang, Science Editor; License (CC BY-NC-ND 4.0), which permits the non- Lucille L. Ye, Science Editor. commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the Acknowledgments formal publication through the relevant DOI and the license). Funding: None. See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

Footnote References

Provenance and Peer Review: This article was commissioned 1. Scopus. Available online: http://www.elsevier.com/ by the editorial office, Translational Cancer Research. The solutions/scopus article did not undergo external peer review.

Cite this article as: Zhong NQ. Translational Cancer Research is indexed in Scopus. Transl Cancer Res 2015;4(4):449-450. doi: 10.3978/j.issn.2218-676X.2015.08.13